MAPT and Mental deterioration: In addition, another study has found that in non-demented individuals at risk for AD, higher concentrations of disease-associated microglia stage 2 (DAM2) are associated with reduced tau aggregation and alleviated cognitive decline, indicating that activation of microglia to DAM2 can delay the progression of AD (Pereira et al., 2022).